Readers suggest … - Letters To The Editor - Brief Article - Letter to the Editor

Journal of Drugs in Dermatology, Dec, 2002

Dear Editor:

Even though the Journal focuses on new drugs, techniques and methods, it would be beneficial if you could include some material on drug reactions. This information is often difficult to come by. It would be beneficial when teaching young doctors that no drug should be used without thoroughly understanding the concept of incompatibility with other medications the patient may be taking and possible adverse reactions.

If we can help in any way in this regard, we would be glad to participate.

Luigi Rusciani Scorza, MD

Chair, Council for National Dermatologic Surgery Societies

Rome, Italy

Dear Dr. Robins,

It would be very helpful and extremely valuable to have a regular column in the Journal about new drugs abroad, which have not reached the FDA approval stage, but which have shown effectiveness for different applications in dermatology and in dermatologic surgery. As we attend more international meetings, we hear about these products. Let us know which companies are doing investigations on these products, so that we can participate in the studies.

Bruce E. Katz, MD

New York, NY